Safety of 100 µg venom immunotherapy rush protocols in children compared to adults.
Johanna StoevesandtChristine HospAndreas KerstanAxel TrautmannPublished in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2017)
The higher anaphylactic reaction rate observed in pediatric patients may be attributed to a greater prevalence of bee venom allergy. VIT-induced anaphylaxis in children is usually mild and does not affect further updosing and maintenance of VIT.